pneumonia plus a high inflammatory response (e.g., elevated C-reactive protein level). ... I believe that [those with] severe pneumonia with a high level of inflammation should.”.
and $1,659 (95% CI, $731 to $2,588; P<0.001) for pneumonia. ... infarction, 84,985 pairs with heart failure, and 74,947 pairs with pneumonia.
Only a positive study has diagnostic value. Aspiration pneumonia (implying infection), aspiration pneumonitis (suggesting chemically induced injury and inflammation), and even aspiration bronchitis are all classified as “complex” pneumonias,
acquired pneumonia (CAP), 238 with health care-associated pneumonia (HCAP), 140 with hospital-acquired pneumonia (HAP), and 55 with ventilator-associated pneumonia (VAP). ... The frequency of multidrug-resistant pathogens varied across pneumonia types
Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. ... A prediction rule to identify allocation of inpatient care in community-acquired pneumonia.
The clinical distinction between community-acquired pneumonia and health care-associated pneumonia is crucial for correct management and antibiotic selection. ... Consider aspiration pneumonia especially when two or more risk factors are present and
hospitals. The study's main outcome measure was postoperative pneumonia. The results were published online Sept. ... However, they concluded that PPIs are associated with an increased risk of postoperative pneumonia in patients who have undergone CABG.
The researchers used logistic regression models to determine the association between screening status and pneumonia rate. ... Heightened vigilance in those who fail screening could help with identifying and treating pneumonia, the authors said.
The study included all hospitalizations in which patients received either therapy for community-onset pneumonia in the Veterans Health Administration health care system from 2008 through 2013. ... The review also found that both types of treatment may
A labeling change for doripenem (Doribax) warning about risk of death for ventilator patients with pneumonia. ... Doripenem is not approved to treat any type of pneumonia. It is still considered safe and effective for its FDA-approved indications: